Bernstein Maintains Outperform on Eli Lilly, Raises Price Target to $1385

Benzinga · 3d ago
Bernstein analyst Courtney Breen maintains Eli Lilly (NYSE:LLY) with a Outperform and raises the price target from $1300 to $1385.